EV/EBITDA
-3.17
-0.14-4.62%
69 min ago
Summary
- As of March 12, 2025, ATXS EV/EBITDA is -3.17, with a fall of -0.14 (-4.62%) during the most recent trading day.
- Over the past year, ATXS EV/EBITDA has increased by +5.97 (+65.32%).
- ATXS EV/EBITDA is now -204.97% below its all-time high of 3.02.
Performance
ATXS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ATXS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -4.6% | +4.4% | +3.5% |
| 1 m1 month | +1.6% | -1.7% | -1.4% |
| 3 m3 months | +38.7% | -38.7% | -33.8% |
| 6 m6 months | +43.6% | -38.2% | -34.1% |
| ytdytd | +25.4% | -25.5% | -21.7% |
| 1 y1 year | +65.3% | -48.4% | -51.7% |
| 5 y5 years | -36.0% | +407.2% | -70.5% |
ATXS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -26.3% | -3.30 | +3.9% | |
| 3 m | 3-month | -2.51 | -26.3% | -5.17 | +38.7% |
| 6 m | 6-month | -2.51 | -26.3% | -7.10 | +55.4% |
| 1 y | 1-year | -2.51 | -26.3% | -10.97 | +71.1% |
| 3 y | 3-year | 0.36 | -980.6% | -10.97 | +71.1% |
| 5 y | 5-year | 3.02 | -205.0% | -10.97 | +71.1% |
| alltime | all time | 3.02 | -205.0% | -10.97 | +71.1% |
Astria Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.17(-25.4%) |
| 2024 | -4.25(+106.3%) |
| 2023 | -2.06(-71.7%) |
| 2022 | -7.29(-1475.5%) |
| 2021 | 0.53(-203.9%) |
| Date | Value |
|---|---|
| 2020 | -0.51(-79.0%) |
| 2019 | -2.43(+291.9%) |
| 2018 | -0.62(-22.5%) |
| 2017 | -0.80(-44.4%) |
| 2016 | -1.44(-33.0%) |
| 2015 | -2.15 |
FAQ
- What is Astria Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Astria Therapeutics?
- What is ATXS EV/EBITDA year-to-date change?
- What is Astria Therapeutics EV/EBITDA year-on-year change?
What is Astria Therapeutics EV/EBITDA?
The current EV/EBITDA of ATXS is -3.17
What is the all time high EV/EBITDA for Astria Therapeutics?
Astria Therapeutics all-time high EV/EBITDA is 3.02
What is ATXS EV/EBITDA year-to-date change?
Astria Therapeutics EV/EBITDA has changed by +1.08 (+25.41%) since the beginning of the year
What is Astria Therapeutics EV/EBITDA year-on-year change?
Over the past year, ATXS EV/EBITDA has changed by +5.97 (+65.32%)